Using in situ hybridization and immunoblot analysis, the present studies id
entified G(z) mRNA and G(z)-protein in the hypothalamic paraventricular nuc
leus. The role of G(z)-proteins in hypothalamic 5-HT1A receptor signaling w
as examined in vivo. Activation of 5-HT1A receptors increases the secretion
of oxytocin and ACTH, but not prolactin. Intracerebroventricular infusion
(3-4 d) of G(z) antisense oligodeoxynucleotides, with different sequences a
nd different phosphorothioate modification patterns, reduced the levels of
G(z)-protein in the hypothalamic paraventricular nucleus, whereas missense
oligodeoxynucleotides had no effect. Neither antisense nor missense oligode
oxynucleotide treatment altered basal plasma levels of ACTH, oxytocin, or p
rolactin, when compared with untreated controls. An antisense-induced decre
ase in hypothalamic G(z)-protein levels was paralleled by a significant dec
rease in the oxytocin and ACTH responses to the 5-HT1A agonist 8-hydroxydip
ropylamino- tetralin (8-OH-DPAT). In contrast, the prolactin response to 8-
OH-DPAT (which cannot be blocked by 5-HT1A antagonists) was not inhibited b
y G(z) antisense oligodeoxynucleotides. G(z)-proteins are the only members
of the G(i)/G(o)-protein family that are not inactivated by pertussis toxin
. In a control experiment, pertussis toxin treatment (1 mu g/5 mu l, i.c.v.
; 48 hr before the 8-OH-DPAT challenge) did not inhibit the ACTH response,
potentiated the oxytocin response, and eliminated the prolactin response to
8-OH-DPAT. Thus, pertussis toxin-sensitive G(i)/G(o)-proteins do not media
te the 5-HT1A receptor-mediated increase in ACTH and oxytocin secretion. Co
mbined, these studies provide the first in vivo evidence for a key role of
G(z)-proteins in coupling hypothalamic 5-HT1A receptors to effector mechani
sms.